Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |